AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
ASTRAZENECA PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $255.76B
- P/E (TTM)
- 25.1
- Dividend yield
- 1.91%
ASTRAZENECA PLC cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 81.9%
- Operating margin
- 23.4%
- Net margin
- 17.4%
- Return on equity, FY2025
- 22.9%
Financial strength
- Current ratio
- 0.89
- Debt to equity
- 0.59
- Debt to assets
- 25.5%
- Cash to current liabilities
- 15.5%
Valuation
- P/E ratio
- 25.1
- Price to sales
- 4.35
- Price to book
- 5.09
- Dividend yield
- 1.91%